IMCI Pharmaceuticals
IMCI is Making Medical Cannabis: Safer, Effective, and Patient-Focused
Company Overview
Snapshot
Founded in December 2018 by Alon Hershkovitz and Avi Yakobovich, IMCI Pharmaceuticals operates with 1–10 employees. The company is currently in a Pre-Funding stage, focusing on advancing medical cannabis solutions.
Business overview
IMCI Pharmaceuticals is a pharma-grade medical cannabis company dedicated to enhancing patient care through scientific rigor, safety, and precision. The company's core technology is the proprietary NanoVATE™ drug-delivery platform, designed to improve cannabinoid bioavailability for fast, accurate, and long-lasting relief. IMCI offers its iCann product line, including iCann Fast, iCann Oral, and iCann LA, targeting global markets across Europe, Israel, and the U.S. with standardized, effective, and stigma-free cannabis treatments. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Cannabis and Drugs Discovery & Development.
Strategic signal
In September 2024, IMCI Pharmaceuticals was featured in an article by nocamels.com highlighting its innovative approach to safer medical cannabis. This signals the company's commitment to addressing patient needs through advanced drug delivery and potentially positions IMCI as a key player in the evolving medical cannabis landscape, emphasizing its focus on patient-centric solutions and market expansion.
Log in to access full profile ›Company Intelligence Q&A
- What is IMCI Pharmaceuticals' primary focus?
- IMCI Pharmaceuticals focuses on redefining patient care through science, safety, and precision in pharma-grade medical cannabis, utilizing its proprietary NanoVATE™ drug-delivery platform.
- What is the NanoVATE™ drug-delivery platform?
- The NanoVATE™ drug-delivery platform is IMCI Pharmaceuticals' proprietary technology designed to enhance cannabinoid bioavailability, enabling fast, accurate, and long-lasting relief for patients.
- What products does IMCI Pharmaceuticals offer?
- IMCI Pharmaceuticals offers the iCann product line, which includes iCann Fast, iCann Oral, and iCann LA, all designed for medical cannabis treatment.
- Where does IMCI Pharmaceuticals plan to expand its operations?
- IMCI Pharmaceuticals is expanding its operations across Europe, Israel, and the U.S., aiming to bring standardized and effective cannabis treatments to global markets.
- When was IMCI Pharmaceuticals founded and by whom?
- IMCI Pharmaceuticals was founded in December 2018 by Alon Hershkovitz and Avi Yakobovich.